<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mossj</journal-id><journal-title-group><journal-title xml:lang="ru">Московский хирургический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Moscow Surgical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-3180</issn><publisher><publisher-name>ООО «ПРОФИЛЬ – 2С»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17238/2072-3180-2024-2-124-130</article-id><article-id custom-type="elpub" pub-id-type="custom">mossj-785</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЛИТЕРАТУРНЫЕ ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LITERARY REVIEWS</subject></subj-group></article-categories><title-group><article-title>Рентгенэндоваскулярное лечение больных со стенотически-окклюзионным поражением аорто-подвздошного сегмента</article-title><trans-title-group xml:lang="en"><trans-title>X-ray endovascular treatment of patients with stenotic-occlusive lesion of the aorto-iliac segment</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6122-4639</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чернявин</surname><given-names>М. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernyavin</surname><given-names>М. Р.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чернявин Максим Павлович – кандидат медицинских наук, рентгеэндоваскулярный хирург</p><p>121352, Москва, Староволынская улица, 10</p></bio><bio xml:lang="en"><p>Chernyavin Maxim Pavlovich – Candidate of Medical Sciences, X-ray endovascular surgeon</p><p>Starovolynskaya street, 10, 121352, Moscow</p></bio><email xlink:type="simple">dr.chernyavin@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9280-8845</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белов</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Belov</surname><given-names>Yu. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Белов Юрий Владимирович – директор института кардиоаортальной хирургии; д.м.н., профессор, академик РАН</p><p>119435, Москва, Абрикосовский пер., д. 2;</p><p>119048, Москва</p></bio><bio xml:lang="en"><p>Belov Yuri Vladimirovich – Director of the Institute of CardioAortic Surgery; Head of the Department of Hospital Surgery</p><p>Abrikosovsky per., 2, 119435, Moscow;</p><p>119048, Moscow</p></bio><email xlink:type="simple">belov_yu_v@staff.sechenov.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Клиническая больница № 1» (Волынская) Управления делами Президента РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Clinical Hospital № 1 (Volynskaya), Presidential Administration of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБНУ «Российский научный центр хирургии им. акад. Б.В. Петровского»; ФГАОУ ВО Первый МГМУ имени И.М. Сеченова Минздрава России (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Petrovsky National Research Centre of Surgery; I.M. Sechenov First Moscow State Medical University (Sechenov University) Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>20</day><month>05</month><year>2024</year></pub-date><volume>0</volume><issue>2</issue><fpage>124</fpage><lpage>130</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Чернявин М.П., Белов Ю.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Чернявин М.П., Белов Ю.В.</copyright-holder><copyright-holder xml:lang="en">Chernyavin М.Р., Belov Y.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mossj.ru/jour/article/view/785">https://www.mossj.ru/jour/article/view/785</self-uri><abstract><sec><title>Введение</title><p>Введение. Хроническая ишемия нижних конечностей – одно из самых распространенных проявлений атеросклеротической болезни у пациентов старшей возрастной группы. Стенотически-окклюзионное поражение аорто-подвздошного сегмента может наблюдаться более чем у 30 % таких больных. В настоящее время лечение таких пациентов может происходить хирургическими методами (эндартерэктомией, аорто-подвздошным или аорто-феморальным шунтированием). Отдаленные послеоперационные исследования демонстрируют удовлетворительные результаты, однако эти операции связаны с высоким риском осложнений и летальности. За последнее время произошли изменения взглядов на подходы к лечению этой патологии. Эндоваскулярные методы становятся все более предпочтительными, особенно у пациентов пожилого возраста, с тяжелой сопутствующей патологией даже при протяженных атеросклеротических поражениях сосудов.</p></sec><sec><title>Заключение</title><p>Заключение. В настоящее время, учитывая тенденцию к увеличению количества больных пожилого возраста с сопутствующей патологией, встречаемости тяжелого протяженного атеросклеротического заболевания, применение эндопротезирования может быть предпочтительной стратегией, особенно при сильно кальцинированных поражениях, когда существует повышенный риск разрыва сосуда. Это наиболее безопасный и эффективный метод реваскуляризации.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Chronic ischemia of the lower extremities is one of the most common manifestations of atherosclerotic disease in patients of the older age group. Stenotic-occlusive lesion of the aorto-iliac segment can be observed in more than 30 % of such patients. Currently, such patients can be treated by surgical methods (endarterectomy, aorto-iliac or aorto-femoral bypass surgery). Long-term postoperative studies show satisfactory results, but these operations are associated with a high risk of complications and mortality. Recently, there have been changes in views on approaches to the treatment of this pathology. Endovascular methods are becoming increasingly preferred, especially in elderly patients with severe concomitant pathology, even with extensive atherosclerotic vascular lesions.</p></sec><sec><title>Conclusion</title><p>Conclusion. Currently, given the tendency to increase the number of elderly patients with concomitant pathology, the occurrence of severe prolonged atherosclerotic disease, the use of endoprosthesis may be the preferred strategy, especially in highly calcified lesions, when there is an increased risk of vessel rupture. This is the safest and most effective method of revascularization.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническая ишемия нижних конечностей</kwd><kwd>аорто-подвздошный сегмент</kwd><kwd>реваскуляризация</kwd><kwd>забрюшинная гематома</kwd><kwd>стент-графт</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic ischemia of the lower extremities</kwd><kwd>aorto-iliac segment</kwd><kwd>revascularization</kwd><kwd>retroperitoneal hematoma</kwd><kwd>stent-graft</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Aronow W.S., Ahn C., Gutstein H. Prevalence and incidence of cardiovascular disease in 1160 older men and 2464 older women in a longterm health care facility. J Gerontol A Biol Sci Med Sci., 2002, № 57(1), рр. M45–M46. https://doi.org/10.1093/gerona/57.1.m45</mixed-citation><mixed-citation xml:lang="en">Aronow W.S., Ahn C., Gutstein H. Prevalence and incidence of cardiovascular disease in 1160 older men and 2464 older women in a longterm health care facility. J Gerontol A Biol Sci Med Sci., 2002, № 57(1), рр. M45–M46. https://doi.org/10.1093/gerona/57.1.m45</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Синявин Г.В., Винокуров И.А., Мнацаканян Г.В., Белов Ю.В. Эпидемиология и патогенез острой ишемии нижних конечностей. Кардиология и сердечно-сосудистая хирургия, 2019. № 12(4). С. 291– 295.</mixed-citation><mixed-citation xml:lang="en">Sinyavin G.V., Vinokurov I.A., Mnatsakanyan G.V., Belov Yu.V. Epidemiology and pathogenesis of acute lower limb ischemia. Cardiology and cardiovascular surgery, 2019, № 12(4), рр. 291–295. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Покровский А.В., Абугов С.А., Алекян Б.Г., Аракелян В.С., Белов Ю.В. и др. Национальные рекомендации по ведению пациентов с заболеваниями артерий нижних конечностей.Российский согласительный документ. Москва, 2013.</mixed-citation><mixed-citation xml:lang="en">Pokrovsky A.V., Abugov S.A., Alekyan B.G., Arakelyan V.S., Belov Yu.V., et al. National guidelines for the management of patients with diseases of the arteries of the lower extremities. The Russian conciliation document. Moscow, 2013. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Белов Ю.В., Синявин Г.В., Винокуров И.А., Мнацаканян Г.В. Частные аспекты острой ишемии нижних конечностей. Кардиология и сердечно-сосудистая хирургия, 2019. № 12(6). С. 564–567. [</mixed-citation><mixed-citation xml:lang="en">Belov Yu.V., Sinyavin G.V., Vinokurov I.A., Mnatsakanyan G.V. Particular aspects of acute ischemia of the lower extremities. Cardiology and cardiovascular surgery, 2019, № 12(6), рр. 564–567. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Paisley M.J., Adkar S., Sheehan B.M., Stern J.R. Aortoiliac occlusive disease. Semin Vasc Surg., 2022, Jun; № 35(2), рр. 162–171. https://doi.org/10.1053/j.semvascsurg.2022.04.005</mixed-citation><mixed-citation xml:lang="en">Paisley M.J., Adkar S., Sheehan B.M., Stern J.R. Aortoiliac occlusive disease. Semin Vasc Surg., 2022, Jun; № 35(2), рр. 162–171. https://doi.org/10.1053/j.semvascsurg.2022.04.005</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Krug R.T., Calligaro K.D., Dougherty M.J. Claudication in the young patient. Perspect Vasc Surg Endovasc Ther., 2000, № 13, рр. 27–38.</mixed-citation><mixed-citation xml:lang="en">Krug R.T. , Calligaro K.D. , Dougherty M.J . Claudication in the young patient. Perspect Vasc Surg Endovasc Ther., 2000, № 13, рр. 27–38.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Selvin E., Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation, 2004, № 110(6), рр. 738–743. https://doi.org/10.1161/01.CIR.0000137913.26087.F0</mixed-citation><mixed-citation xml:lang="en">Selvin E., Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation, 2004, № 110(6), рр. 738–743. https://doi.org/10.1161/01.CIR.0000137913.26087.F0</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Wooten C., Hayat M., du Plessis M. et al. Anatomical significance in aortoiliac occlusive disease. Clin Anat., 2014, № 27(8), рр. 1264–1274. https://doi.org/10.1002/ca.22444</mixed-citation><mixed-citation xml:lang="en">Wooten C., Hayat M., du Plessis M. et al. Anatomical significance in aortoiliac occlusive disease. Clin Anat., 2014, № 27(8), рр. 1264–1274. https://doi.org/10.1002/ca.22444</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Katsaros I., Georgakarakos E., Frigkas K. et al. Arterial collateral circulation pathways in patients with aortoiliac occlusive disease. Vascular, 2019, № 27, рр. 677–683.</mixed-citation><mixed-citation xml:lang="en">Katsaros I., Georgakarakos E., Frigkas K. et al. Arterial collateral circulation pathways in patients with aortoiliac occlusive disease. Vascular, 2019, № 27, рр. 677–683.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Aboyans V., Ricco J.B., Bartelink M.E.L. et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Rev Esp Cardiol (Engl Ed), 2018, № 71(2), рр. 111. https://doi.org/10.1016/j.rec.2017.12.014</mixed-citation><mixed-citation xml:lang="en">Aboyans V., Ricco J.B., Bartelink M.E.L. et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Rev Esp Cardiol (Engl Ed), 2018, № 71(2), рр. 111. https://doi.org/10.1016/j.rec.2017.12.014</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Fowler B., Jamrozik K., Norman P., Allen Y., Wilkinson E. Improving maximum walking distance in early peripheral arterial disease: randomised controlled trial. Aust J Physiother, 2002, № 48(4), рр. 269–275. https://doi.org/10.1016/s0004-9514(14)60166-5</mixed-citation><mixed-citation xml:lang="en">Fowler B., Jamrozik K., Norman P., Allen Y., Wilkinson E. Improving maximum walking distance in early peripheral arterial disease: randomised controlled trial. Aust J Physiother, 2002, № 48(4), рр. 269–275. https://doi.org/10.1016/s0004-9514(14)60166-5</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hess C.N., Norgren L., Ansel G.M. et al. A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative. Circulation, 2017, № 135(25), рр. 2534–2555. https://doi.org/10.1161/CIRCULATIONAHA.117.024469</mixed-citation><mixed-citation xml:lang="en">Hess C.N., Norgren L., Ansel G.M. et al. A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative. Circulation, 2017, № 135(25), рр. 2534–2555. https://doi.org/10.1161/CIRCULATIONAHA.117.024469</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Steffel J., Eikelboom J.W., Anand S.S., Shestakovska O., Yusuf S., Fox K.A.A. The COMPASS Trial: Net Clinical Benefit of Low-Dose Rivaroxaban Plus Aspirin as Compared With Aspirin in Patients With Chronic Vascular Disease Circulation, 2020, № 142(1), рр. 40–48. https://doi.org/10.1161/CIRCULATIONAHA.120.046048</mixed-citation><mixed-citation xml:lang="en">Steffel J., Eikelboom J.W., Anand S.S., Shestakovska O., Yusuf S., Fox K.A.A. The COMPASS Trial: Net Clinical Benefit of Low-Dose Rivaroxaban Plus Aspirin as Compared With Aspirin in Patients With Chronic Vascular Disease Circulation, 2020, № 142(1), рр. 40–48. https://doi.org/10.1161/CIRCULATIONAHA.120.046048</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, № 348(9038), рр. 1329–1339. https://doi.org/10.1016/s0140-6736(96)09457-3</mixed-citation><mixed-citation xml:lang="en">CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, № 348(9038), рр. 1329–1339. https://doi.org/10.1016/s0140-6736(96)09457-3</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Zil-E-Ali A., Medina D., Orozco D., Yang Q., Aziz F. Preoperative Statin Use is Associated With Lower Incidence of Limb Loss After Lower Extremity Endovascular Interventions. Am Surg., 2022, № 88(11), рр. 2719–2729. https://doi.org/10.1177/00031348211068000</mixed-citation><mixed-citation xml:lang="en">Zil-E-Ali A., Medina D., Orozco D., Yang Q., Aziz F. Preoperative Statin Use is Associated With Lower Incidence of Limb Loss After Lower Extremity Endovascular Interventions. Am Surg., 2022, № 88(11), рр. 2719–2729. https://doi.org/10.1177/00031348211068000</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Norgren L., Hiatt W.R., Dormandy J.A. et al. Inter-society consensus for the management of peripheral arterial disease. Int Angiol., 2007, № 26(2), рр. 81–157.</mixed-citation><mixed-citation xml:lang="en">Norgren L., Hiatt W.R., Dormandy J.A. et al. Inter-society consensus for the management of peripheral arterial disease. Int Angiol., 2007, № 26(2), рр. 81–157.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Salem M., Hosny M.S., Francia F. et al. Management of Extensive Aorto-Iliac Disease: A Systematic Review and Meta-Analysis of 9319 Patients. Cardiovasc Intervent Radiol., 2021, № 44(10), рр. 1518–1535. https://doi.org/10.1007/s00270-021-02785-6</mixed-citation><mixed-citation xml:lang="en">Salem M., Hosny M.S., Francia F. et al. Management of Extensive Aorto-Iliac Disease: A Systematic Review and Meta-Analysis of 9319 Patients. Cardiovasc Intervent Radiol., 2021, № 44(10), рр. 1518–1535. https:// doi.org/10.1007/s00270-021-02785-6</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Squizzato F., D’Oria M., Bozza R., Porcellato L., Grego F., Lepidi S.. Propensity-Matched Comparison of Endovascular versus Open Reconstruction for TASC-II C/D AortoIliac Occlusive Disease. A Ten-Year Single-Center Experience with Self-Expanding Covered Stents. Ann Vasc Surg., 2021, № 71, рр. 84–95. https://doi.org/10.1016/j.avsg.2020.08.139</mixed-citation><mixed-citation xml:lang="en">Squizzato F., D’Oria M., Bozza R., Porcellato L., Grego F., Lepidi S.. Propensity-Matched Comparison of Endovascular versus Open Reconstruction for TASC-II C/D AortoIliac Occlusive Disease. A Ten-Year Single-Center Experience with Self-Expanding Covered Stents. Ann Vasc Surg., 2021, № 71, рр. 84–95. https://doi.org/10.1016/j.avsg.2020.08.139</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ye W., Liu C.W., Ricco J.B., Mani K., Zeng R., Jiang J. Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions. J Vasc Surg., 2011, № 53(6), рр. 1728–1737. https://doi.org/10.1016/j.jvs.2011.02.005</mixed-citation><mixed-citation xml:lang="en">Ye W., Liu C.W., Ricco J.B., Mani K., Zeng R., Jiang J. Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions. J Vasc Surg., 2011, № 53(6), рр. 1728–1737. https://doi.org/10.1016/j.jvs.2011.02.005</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Bredahl K., Jensen L.P., Schroeder T.V., Sillesen H., Nielsen H., Eiberg J.P. Mortality and complications after aortic bifurcated bypass procedures for chronic aortoiliac occlusive disease. J Vasc Surg., 2015, № 62(1), рр. 75–82. https://doi.org/10.1016/j.jvs.2015.02.025</mixed-citation><mixed-citation xml:lang="en">Bredahl K., Jensen L.P., Schroeder T.V., Sillesen H., Nielsen H., Eiberg J.P. Mortality and complications after aortic bifurcated bypass procedures for chronic aortoiliac occlusive disease. J Vasc Surg., 2015, № 62(1), рр. 75–82. https://doi.org/10.1016/j.jvs.2015.02.025</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Khashram M., Williman J.A., Hider P.N., Jones G.T., Roake J.A. Systematic Review and Meta-analysis of Factors Influencing Survival Following Abdominal Aortic Aneurysm Repair. Eur J Vasc Endovasc Surg., 2016, № 51(2), рр. 203–215. https://doi.org/10.1016/j.ejvs.2015.09.007</mixed-citation><mixed-citation xml:lang="en">Khashram M., Williman J.A., Hider P.N., Jones G.T., Roake J.A. Systematic Review and Meta-analysis of Factors Influencing Survival Following Abdominal Aortic Aneurysm Repair. Eur J Vasc Endovasc Surg., 2016, № 51(2), рр. 203–215. https://doi.org/10.1016/j.ejvs.2015.09.007</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Haimivici H., ed. Haimovici’s Vascular Surgery. 5th ed. Oxford, UK: Blackwell Publishing Ltd, 2004. https://doi.org/10.1002/9781118481370</mixed-citation><mixed-citation xml:lang="en">Haimivici H., ed. Haimovici’s Vascular Surgery. 5th ed. Oxford, UK: Blackwell Publishing Ltd, 2004. https://doi.org/10.1002/9781118481370</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Koizumi A., Kumakura H., Kanai H. et al. Ten-year patency and factors causing restenosis after endovascular treatment of iliac artery lesions. Circ J.. 2009, № 73(5), рр. 860–866. https://doi.org/10.1253/circj.cj08-0765</mixed-citation><mixed-citation xml:lang="en">Koizumi A., Kumakura H., Kanai H. et al. Ten-year patency and factors causing restenosis after endovascular treatment of iliac artery lesions. Circ J.. 2009, № 73(5), рр. 860–866. https://doi.org/10.1253/circj.cj-08-0765</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Lakhter V., Aggarwal V. Current Status and Outcomes of Iliac Artery Endovascular Intervention. Interv Cardiol Clin., 2017, № 6(2), рр. 167–180. https://doi.org/10.1016/j.iccl.2016.12.001</mixed-citation><mixed-citation xml:lang="en">Lakhter V., Aggarwal V. Current Status and Outcomes of Iliac Artery Endovascular Intervention. Interv Cardiol Clin., 2017, № 6(2), рр. 167–180. https://doi.org/10.1016/j.iccl.2016.12.001</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Yang M., Zhang B., Niu G., Yan Z., Tong X., Zou Y. Long-term results of endovascular reconstruction for aortoiliac occlusive disease. Quant Imaging Med Surg, 2021, № 11(4), рр. 1303–1312. https://doi.org/10.21037/qims-20-599</mixed-citation><mixed-citation xml:lang="en">Yang M., Zhang B., Niu G., Yan Z., Tong X., Zou Y. Long-term results of endovascular reconstruction for aortoiliac occlusive disease. Quant Imaging Med Surg, 2021, № 11(4), рр. 1303–1312. https://doi.org/10.21037/qims-20-599</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Bosch J.L., Hunink M.G.M. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement of aortoiliac occlusive disease. Radiology, 1997, № 204, рр. 87–96.</mixed-citation><mixed-citation xml:lang="en">Bosch J.L., Hunink M.G.M. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement of aortoiliac occlusive disease. Radiology, 1997, № 204, рр. 87–96.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Lammer J., Dake M.D., Bleyn J. et al. Peripheral arterial obstruction: prospective study of treatment with a transluminally placed selfexpanding stent-graft. International Trial Study Group. Radiology, 2000, № 217(1), рр. 95–104. https://doi.org/10.1148/radiology.217.1.r00se0595</mixed-citation><mixed-citation xml:lang="en">Lammer J., Dake M.D., Bleyn J. et al. Peripheral arterial obstruction: prospective study of treatment with a transluminally placed selfexpanding stent-graft. International Trial Study Group. Radiology, 2000, № 217(1), рр. 95–104. https://doi.org/10.1148/radiology.217.1.r00se0595</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Tomoi Y., Takahara M., Soga Y. et al. Clinical outcome of endovascular therapy using a VIABAHN VBX-covered stent for complex aortoiliac artery disease: the AVOCADO II study. Heart Vessels. 2023, № 38(10), рр. 1288–1297. https://doi.org/10.1007/s00380-023-02274-5</mixed-citation><mixed-citation xml:lang="en">Tomoi Y., Takahara M., Soga Y. et al. Clinical outcome of endovascular therapy using a VIABAHN VBX-covered stent for complex aortoiliac artery disease: the AVOCADO II study. Heart Vessels. 2023, № 38(10), рр. 1288–1297. https://doi.org/10.1007/s00380-023-02274-5</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Maynar M., Reyes R., Ferral H. et al. Cragg Endopro-I: early experience in femoral arteries. J Vasc Interv Radiol, 1997, № 8, рр. 203–207.</mixed-citation><mixed-citation xml:lang="en">Maynar M., Reyes R., Ferral H. et al. Cragg Endopro-I: early experience in femoral arteries. J Vasc Interv Radiol, 1997, № 8, рр. 203–207.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Maldonado T.S., Westin G.G., Jazaeri O., Mewissen M., Reijnen M.M., Dwivedi A.J., Garrett H.E. Jr., Dias Perera A., Shimshak T., Mantese V., Smolock C.J., Arthurs Z.M. Treatment of Aortoiliac Occlusive Disease with the Endologix AFX Unibody Endograft. Eur J Vasc Endovasc Surg., 2016, Jul; № 52(1), рр. 64–74. https://doi.org/10.1016/j.ejvs.2016.04.003</mixed-citation><mixed-citation xml:lang="en">Maldonado T.S., Westin G.G., Jazaeri O., Mewissen M., Reijnen M.M., Dwivedi A.J., Garrett H.E. Jr., Dias Perera A., Shimshak T., Mantese V., Smolock C.J., Arthurs Z.M. Treatment of Aortoiliac Occlusive Disease with the Endologix AFX Unibody Endograft. Eur J Vasc Endovasc Surg., 2016, Jul; № 52(1), рр. 64–74. https://doi.org/10.1016/j.ejvs.2016.04.003</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
